Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wiman

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
European Journal of Biochemistry|March 15, 1978
On the kinetics of the reaction between human antiplasmin and plasminB Wiman, D Collen
European Journal of Biochemistry|January 1, 1983
Kinetics of the reaction between human C1-esterase inhibitor and C1r or C1sT Nilsson, B Wiman
Nature|April 6, 1978
Molecular mechanism of physiological fibrinolysisB Wiman, D Collen
The Journal of Biological Chemistry|September 25, 1979
On the mechanism of the reaction between human alpha 2-antiplasmin and plasminB Wiman, D Collen
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1985
A novel fast inhibitor to tissue plasminogen activator in plasma, which may be of great pathophysiological significanceB Wiman, J Chmielewska
European Journal of Biochemistry|August 15, 1977
Purification and characterization of human antiplasmin, the fast-acting plasmin inhibitor in plasmaB Wiman, D Collen
Clinical Chemistry|March 1, 1986
Determination of tissue plasminogen activator and its "fast" inhibitor in plasmaJ Chmielewska, B Wiman
Thrombosis and Haemostasis|April 1, 1996
The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study GroupS Schulman, B Wiman
Thrombosis and Haemostasis|April 30, 1986
Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assayB Wiman, M Rånby
Biochimica Et Biophysica Acta|July 26, 1982
Purification and characterization of human C1-esterase inhibitorT Nilsson, B Wiman
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
European Journal of Biochemistry|March 15, 1978
On the kinetics of the reaction between human antiplasmin and plasminB Wiman, D Collen
European Journal of Biochemistry|January 1, 1983
Kinetics of the reaction between human C1-esterase inhibitor and C1r or C1sT Nilsson, B Wiman
Nature|April 6, 1978
Molecular mechanism of physiological fibrinolysisB Wiman, D Collen
The Journal of Biological Chemistry|September 25, 1979
On the mechanism of the reaction between human alpha 2-antiplasmin and plasminB Wiman, D Collen
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1985
A novel fast inhibitor to tissue plasminogen activator in plasma, which may be of great pathophysiological significanceB Wiman, J Chmielewska
European Journal of Biochemistry|August 15, 1977
Purification and characterization of human antiplasmin, the fast-acting plasmin inhibitor in plasmaB Wiman, D Collen
Clinical Chemistry|March 1, 1986
Determination of tissue plasminogen activator and its "fast" inhibitor in plasmaJ Chmielewska, B Wiman
Thrombosis and Haemostasis|April 1, 1996
The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study GroupS Schulman, B Wiman
Thrombosis and Haemostasis|April 30, 1986
Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assayB Wiman, M Rånby
Biochimica Et Biophysica Acta|July 26, 1982
Purification and characterization of human C1-esterase inhibitorT Nilsson, B Wiman
Pageof 13